Sirona Biochem (SBM) Sets New 52-Week High at $0.35

Shares of Sirona Biochem Corp (CVE:SBM) hit a new 52-week high during mid-day trading on Tuesday . The stock traded as high as C$0.35 and last traded at C$0.32, with a volume of 753750 shares trading hands. The stock had previously closed at C$0.32.

The company has a market cap of $47.32 million and a PE ratio of -42.50.

In other news, Director Howard Jarman Verrico sold 460,000 shares of the stock in a transaction that occurred on Friday, February 22nd. The shares were sold at an average price of C$0.11, for a total value of C$50,600.00. Following the completion of the sale, the director now owns 5,791,250 shares of the company’s stock, valued at approximately C$637,037.50.

TRADEMARK VIOLATION NOTICE: “Sirona Biochem (SBM) Sets New 52-Week High at $0.35” was originally posted by WKRB News and is owned by of WKRB News. If you are viewing this article on another publication, it was illegally stolen and republished in violation of United States and international copyright and trademark legislation. The correct version of this article can be read at

About Sirona Biochem (CVE:SBM)

Sirona Biochem Corp. operates as a cosmetic ingredient and drug discovery company in Canada and France. The company develops programs in three areas, including diabetes, anti-inflammatories, and anti-infectives for therapeutics; anti-aging and depigmenting agents in cosmeceuticals; and biological ingredients, such as inducers and adjuvants for the biological development and preservation.

Featured Story: What Does a Sell-Side Analyst Rating Mean?

Receive News & Ratings for Sirona Biochem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sirona Biochem and related companies with's FREE daily email newsletter.